Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXCP.L Regulatory News (MXCP)

  • There is currently no data for MXCP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

27 Feb 2012 11:30

RNS Number : 1771Y
2 ergo Group plc
27 February 2012
 



27 February 2012

 

2ergo Group plc

 

Sale of international operations for $3.8m

 

 

Introduction

 

2ergo Group plc (AIM: RGO, "2ergo" or "the Group"), the mobile solutions company, has sold its three international businesses for $3.8m as part of a strategic restructuring programme initiated last year.

 

Details of the Disposals

 

To fulfil a major part of the Group's strategy, on Friday 24 February 2012 2ergo sold 2ergo Americas Inc, which represented its non-core North and Latin American operations, to Nasdaq-listed SoundBite Communications Inc ("SoundBite", NASDAQ: SDBT). SoundBite now becomes a key partner of the Group in the US.

 

Consideration for the disposal was $3.8m in cash, of which $3m was paid on completion. The balance will be held in escrow to settle any warranty claims arising and is expected to be released over a two year period. In the year to 31 August 2011, the loss before tax of 2ergo Americas Inc was $0.7m.

 

Importantly, the Group has retained 2ergo Inc. in the US which operates 2ergo's strategic partnership with Microsoft's Innovation Outreach Programme. This business is performing well and delivering important contract wins from, for example, Wendy's Restaurants and 3M. The Group views such regional partnerships as central to its geographical sales strategy going forward.

 

The Group has also sold its Australian operations to Gomeeki Pty Limited, one of its key partners in the country, and its Indian operations to the Indian management, whilst retaining important technology and IP. The latter transaction also completed on Friday 24 February and the former completed today. Consideration for these two disposals was nominal.

 

Outlook

 

Due to the strategic restructuring programme, which included the termination of sub-scale UK operations and legacy business lines, and the continuing challenging trading environment, the Group's profitability for H1 to 29 February 2012 is now expected to be below the Board's original expectations. However, the restructuring leaves the Group more focused than ever before and the disposals are expected to reduce the Group's operating costs by approximately £250,000 per month. The Group's excellent sales pipeline remains in place, although deals continue to take longer than usual to close due to the current economic climate.

 

The proceeds of the sales will be invested in accelerating the roll-out of podifi, 2ergo's new patented contactless mobile coupon and payment redemption technology launched today during the Mobile World Congress (see separate announcement).

 

podifi is the culmination of 12 years' experience in delivering customer acquisition technology for clients including Orange Wednesdays, reputed to be the world's most successful mobile loyalty programme. podifi will become one of the Group's core market propositions.

 

Neale Graham, CEO of 2ergo, said:

 

"As part of the review accompanying our restructuring programme, we concluded that our overseas operations were sub-scale and not in line with the Group's core strategy. As a result, we have taken advantage of attractive opportunities to dispose of these operations whilst maintaining market presence through high quality partners such as our new partner SoundBite.

 

"Although the strategic restructuring has been a distraction for the management, we are now a focused operation and in an excellent position to capitalise on the numerous opportunities we are seeing in our core business and especially the potential of podifi, our ground breaking contactless mobile coupon and payment technology. We look forward to announcing the progress of podifi in due course."

 

This announcement is being timed to coincide with an equivalent announcement being released by SoundBite in the United States.

 

 

Enquiries:

 

2ergo Group plc

Neale Graham, CEO

Tel: +44(0)161 874 4222

Jill Collighan, Group Finance Director

Numis Securities

Stuart Skinner, as Nominated Adviser

Tel: +44(0)20 7260 1000

David Poutney, as Corporate Broker

College Hill

Adrian Duffield/Jon Davies

Tel: +44(0)20 7457 2020

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISLLFLLFTIDFIF
Date   Source Headline
20th Aug 20185:10 pmRNSSale of Castleton Shares
14th Aug 20187:00 amRNSConversion of Loan Notes in Castleton Technology
6th Aug 20181:30 pmRNSHolding(s) in Company
6th Aug 20181:30 pmRNSHolding(s) in Company
6th Aug 20187:00 amRNSFurther Investment / Sale of Shares
31st Jul 20187:00 amRNSProposed investment in IDE Group Holdings
19th Jul 20187:00 amRNSAcquisition by Ravenscroft of 25% shareholding
21st Jun 20188:25 amRNSHolding(s) in Company
21st Jun 20187:56 amRNSSale of Castleton Shares
12th Jun 201810:18 amRNSIssue of Equity / Total Voting Rights
30th May 20187:00 amRNSSubscription for Loan Notes in IDE Group Holdings
9th May 20187:00 amRNSInterim Results
23rd Apr 20187:00 amRNSFirst Investment into Joint Venture Liberty Global
11th Apr 20181:46 pmRNSPurchase of IDE Shares
10th Apr 20187:00 amRNSSale of Castleton Shares
21st Feb 20187:00 amRNSExercise of Castleton Option
16th Feb 20187:00 amRNSAppointed consultant to Ravenscroft Limited
13th Feb 20181:54 pmRNSResult of AGM
29th Jan 20187:00 amRNSPosting of Annual Report and Accounts
4th Dec 20177:00 amRNSBoard Change
4th Dec 20177:00 amRNSFinal Results for the Year Ended 31 August 2017
22nd Nov 20174:40 pmRNSSecond Price Monitoring Extn
22nd Nov 20174:35 pmRNSPrice Monitoring Extension
21st Nov 20172:36 pmRNSIssue of Equity / Total Voting Rights
20th Nov 20177:00 amRNSJoint Venture with Liberty Global
3rd Nov 201712:54 pmRNSNotice of Annual Results
21st Sep 20172:02 pmRNSHolding(s) in Company
25th Aug 201710:20 amRNSTransaction in Own Shares / Total Voting Rights
1st Aug 20177:00 amRNSResignation as Financial Adviser to CORETX
30th Jun 20174:19 pmRNSTransaction in Own Shares / Total Voting Rights
30th Jun 201710:15 amRNSTransaction in Own Shares / Total Voting Rights
28th Jun 20171:56 pmRNSTransaction in Own Shares / Total Voting Rights
27th Jun 20175:13 pmRNSTransaction in Own Shares / Total Voting Rights
26th Jun 201711:48 amRNSTransaction in Own Shares / Total Voting Rights
23rd Jun 20174:23 pmRNSTransaction in Own Shares / Total Voting Rights
23rd Jun 201711:36 amRNSTransaction in Own Shares / Total Voting Rights
21st Jun 20173:28 pmRNSTransaction in Own Shares / Total Voting Rights
21st Jun 201712:41 pmRNSTransaction in Own Shares / Total Voting Rights
15th Jun 20174:17 pmRNSTransaction in Own Shares / Total Voting Rights
13th Jun 20179:30 amRNSTransaction in Own Shares / Total Voting Rights
9th Jun 20171:42 pmRNSTransaction in Own Shares/ Total Voting Rights
8th Jun 20175:18 pmRNSTransaction in Own Shares/ Total Voting Rights
6th Jun 20174:22 pmRNSTransaction in Own Shares / Total Voting Rights
5th Jun 20174:33 pmRNSTransaction in Own Shares / Total Voting Rights
31st May 20175:27 pmRNSTransaction in own shares/Total voting rights
31st May 20179:46 amRNSTransaction in Own Shares/ Total Voting Rights
25th May 20174:20 pmRNSTransaction in Own Shares / Total Voting Rights
24th May 20174:14 pmRNSTransaction in Own Shares
24th May 201710:17 amRNSTransaction in Own Shares / Total Voting Rights
22nd May 20176:11 pmRNSTransaction in Own Shares / Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.